Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Cytek Biosciences Inc - SIC # 3845 - ELECTROMEDICAL AND ELECTROTHERAPEUTIC APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
CTKB
Nasdaq
3845
https://cytekbio.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Cytek Biosciences Inc
Cytek Biosciences (CTKB) Loses -7.27% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
- Apr 11th, 2024 1:35 pm
Wall Street Analysts Believe Cytek Biosciences (CTKB) Could Rally 47.61%: Here's is How to Trade
- Apr 10th, 2024 1:55 pm
Insider Sell: Cytek Biosciences Inc's (CTKB) Chief Technology Officer Ming Yan Sells 40,000 Shares
- Mar 20th, 2024 5:50 am
Cytek® Biosciences Names William McCombe Chief Financial Officer
- Mar 19th, 2024 12:00 pm
Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions
- Mar 7th, 2024 10:30 pm
Cytek Biosciences Reports Full Year 2023 Earnings
- Mar 1st, 2024 6:30 pm
Cytek Biosciences Inc (CTKB) Reports Robust Revenue Growth and Positive Net Income in Q4 2023
- Mar 1st, 2024 11:31 am
Cytek Biosciences, Inc. (NASDAQ:CTKB) Q4 2023 Earnings Call Transcript
- Feb 29th, 2024 3:26 pm
Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook
- Feb 28th, 2024 10:05 pm
ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- Feb 22nd, 2024 3:00 pm
Earnings Preview: Cytek Biosciences, Inc. (CTKB) Q4 Earnings Expected to Decline
- Feb 21st, 2024 3:00 pm
After losing 27% in the past year, Cytek Biosciences, Inc. (NASDAQ:CTKB) institutional owners must be relieved by the recent gain
- Feb 13th, 2024 12:04 pm
Cytek Biosciences to Participate in Upcoming Investor Conferences
- Feb 7th, 2024 9:10 pm
Cytek Biosciences to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
- Feb 7th, 2024 9:05 pm
Cytek® Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries
- Jan 17th, 2024 10:30 pm
Cytek Biosciences, Inc. (CTKB) Surges 10.3%: Is This an Indication of Further Gains?
- Jan 9th, 2024 10:56 am
Cytek Biosciences Announces Preliminary Full Year 2023 Revenue Results
- Jan 8th, 2024 2:00 pm
Cytek Biosciences to present at the 42nd Annual J.P. Morgan Healthcare Conference
- Dec 28th, 2023 9:05 pm
Insider Sell: Cytek Biosciences Inc's CTO Ming Yan Disposes of 20,000 Shares
- Dec 22nd, 2023 2:01 pm
Cytek® Biosciences Introduces the Cytek Orion™ Reagent Cocktail Preparation System, the First-of-its-Kind Automated Cocktail Preparation Instrument for Flow Cytometry
- Dec 21st, 2023 2:00 pm
Scroll